Screener
Cardiff Oncology CRDF Q1 2025 earnings
Reported May 8, 2025 · Before market open
Revenue$109.0KBeat by $19.7K
EPS-$0.20Miss by $0.01
Revenue estimate$89.3K
EPS estimate-$0.19
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$67.2K
EPS estimate-$0.15
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Cardiff Oncology report Q1 2025 earnings?
- Cardiff Oncology (CRDF) reported Q1 2025 earnings on May 8, 2025 before market open.
- What were Cardiff Oncology's Q1 2025 revenue and EPS?
- Cardiff Oncology reported revenue of $109.0K and eps of $-0.20 for Q1 2025.
- Did Cardiff Oncology beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $89.3K by $19.7K. EPS missed the consensus estimate of $-0.19 by $0.01.
- How did Cardiff Oncology's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 46.8% from $205.0K a year earlier and eps grew 9.1% from $-0.22.
- Where can I find Cardiff Oncology's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-066947) and the 10-Q periodic report (0000950170-25-066886) directly on SEC EDGAR. The filing index links above go to sec.gov.
